Class A Common Stock to Resume Trading on Nasdaq Organogenesis Holdings Inc. (the “Company”) (Nasdaq: ORGO; ORGOW) today announced that on January 4, 2019, the Company was notified by The Nasdaq Stock Market LLC (“Nasdaq”) that, based on the plan of compliance presented by the Company at its hearing, the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request for the continued listing of its Class A common stock on The Nasdaq Capital Market. Pursuant to the Panel’s decision, on or before March 31, 2019, the Company is required to demonstrate to the satisfaction of Staff and the Panel that it has a minimum of 300 round lot shareholders of its Class A common stock and that it otherwise meets all applicable requirements for listing on Nasdaq.

Click here to read the full article.